Standard BioTools Inc. (FLDM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Standard BioTools Inc.

    NASDAQ: FLDM · Real-Time Price · USD
    3.71
    -0.28 (-7.02%)
    At close: Apr 06, 2022, 6:00 AM

    Standard BioTools Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2021
    Period Ending Dec 31, 2021
    Revenue
    		 130.58M
    Cost of Revenue
    		 61.21M
    Gross Profit
    		 69.37M
    Operating Income
    		 -59.84M
    Interest Income
    		 n/a
    Pretax Income
    		 -63.66M
    Net Income
    		 -59.24M
    Selling & General & Admin
    		 98.89M
    Research & Development
    		 37.94M
    Other Expenses
    		 n/a
    Operating Expenses
    		 136.83M
    Interest Expense
    		 3.82M
    Selling & Marketing Expenses
    		 n/a
    Cost & Expenses
    		 198.04M
    Income Tax Expense
    		 -4.42M
    Shares Outstanding (Basic)
    		 76.3M
    Shares Outstanding (Diluted)
    		 76.3M
    EPS (Basic)
    		 -0.78
    EPS (Diluted)
    		 -0.78
    EBITDA
    		 -44.27M
    EBIT
    		 -59.84M
    Depreciation & Amortization
    		 15.57M

    Add to Watchlist